Journey Medical (DERM) COO receives new RSU and option grants

Rhea-AI Filing Summary

Journey Medical Corp Chief Operating Officer Ramsey Alloush received new equity awards as part of compensation. On April 22, 2026, he was granted 46,863 restricted stock units that vest in three equal installments on April 22 of 2027, 2028, and 2029. He also received stock options for 62,795 shares of common stock at an exercise price of $5.04 per share, vesting on the same dates. After these awards, he directly owns 598,543 shares of common stock, including restricted stock units. The options expire on April 22, 2036, giving him long-term upside exposure tied to the company’s share price.

Insights

Equity compensation analyst

Routine long-term equity grants to Journey Medical’s COO increase incentive alignment.

Ramsey Alloush, Chief Operating Officer of Journey Medical Corp, received 46,863 restricted stock units and 62,795 stock options at an exercise price of $5.04 per share. Both awards vest in three annual tranches from 2027 to 2029, encouraging multi‑year retention.

These are compensation-related acquisitions, not open‑market purchases or sales, so they carry limited signaling value about management’s view of the stock. Following the grants, Alloush holds 598,543 common shares directly, highlighting substantial ongoing exposure to company performance.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Alloush Ramsey

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	62,795	$0.00	--
Grant/Award	Common Stock, $0.0001 par value	46,863	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 62,795 shares (Direct, null); Common Stock, $0.0001 par value — 598,543 shares (Direct, null)

Footnotes (1)

1. On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029. Includes restricted stock units, which vest over various time periods. On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029.

Key Figures

Restricted stock units granted: 46,863 RSUs RSU vesting tranches: 15,621 shares each year Stock options granted: 62,795 options +4 more

7 metrics

Restricted stock units granted 46,863 RSUs Granted April 22, 2026 under 2015 Stock Plan

RSU vesting tranches 15,621 shares each year Vest on April 22 of 2027, 2028, 2029

Stock options granted 62,795 options Granted April 22, 2026 under 2015 Stock Plan

Option exercise price $5.04 per share Stock Option (Right to Buy) for common stock

Option vesting tranches 20,932/20,932/20,931 shares Vest on April 22 of 2027, 2028, 2029

Option expiration April 22, 2036 Expiration date of granted stock options

Shares owned after grants 598,543 shares Common stock directly held following transactions

Key Terms

restricted stock units, 2015 Stock Plan, stock options, exercise price, +1 more

5 terms

restricted stock units financial

"the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2015 Stock Plan financial

"pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest"

stock options financial

"the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"Stock Option (Right to Buy) with a conversion or exercise price of 5.0400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting schedule financial

"that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027"

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alloush Ramsey

(Last) (First) (Middle)

C/O JOURNEY MEDICAL CORPORATION

9237 E VIA DE VENTURA BLVD., SUITE 105

(Street)

SCOTTSDALE ARIZONA 85258

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Journey Medical Corp [ DERM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	04/22/2026		A		46,863(1)	A	$0	598,543(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$5.04	04/22/2026		A		62,795		(3)	04/22/2036	Common Stock, $0.0001 par value	62,795	$0	62,795	D

Explanation of Responses:

1. On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029.

2. Includes restricted stock units, which vest over various time periods.

3. On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029.

	/s/ Ramsey Alloush	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Journey Medical (DERM) grant to its COO on April 22, 2026?

Journey Medical granted COO Ramsey Alloush 46,863 restricted stock units and stock options for 62,795 shares on April 22, 2026. Both awards were issued under the company’s 2015 Stock Plan, as amended, and are designed as long-term incentive compensation rather than cash salary.

How do the new restricted stock units for Journey Medical’s COO vest?

The 46,863 restricted stock units vest in three equal annual installments of 15,621 shares on April 22, 2027, April 22, 2028, and April 22, 2029. This time-based vesting structure encourages the COO to remain with Journey Medical while focusing on longer-term company performance.

What are the key terms of the new stock options granted to Journey Medical’s COO?

The COO received stock options covering 62,795 shares of Journey Medical common stock at an exercise price of $5.04 per share. These options vest in three tranches: 20,932 shares on April 22, 2027, 20,932 on April 22, 2028, and 20,931 on April 22, 2029, and expire on April 22, 2036.

How many Journey Medical shares does the COO hold after these Form 4 transactions?

After the reported grants, COO Ramsey Alloush directly holds 598,543 shares of Journey Medical common stock. This figure includes restricted stock units that vest over various time periods, indicating a sizable ongoing equity stake tied to the company’s future results and share price performance.

Are these Journey Medical Form 4 transactions open-market buys or compensation grants?

These Form 4 entries reflect compensation-related grants, not open-market trades. The COO acquired restricted stock units and stock options under Journey Medical’s 2015 Stock Plan, as amended. The transaction code "A" indicates awards or other acquisitions, rather than discretionary market purchases or sales of existing shares.